Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Alkermes, Inc.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
18-70 years of age
Has a BMI ≥18 and ≤40 kg/m2
Meets the diagnostic criteria of Narcolepsy type 1 according to ICSD-3-TR guidelines. Additionally, meets the following criteria:
* Is HLA-DQB1\*06:02-positive
* Has residual excessive daytime sleepiness and cataplexy
Is willing and able to discontinue any medications prescribed for the management of narcolepsy symptoms for at least 14 days and for the duration of study
Is willing to adhere to additional protocol requirements
You may not be if
Significant comorbid medical conditions, including other sleep, cardiovascular, psychiatric, hepatic or other disorders may be exclusionary; eligibility will be determined on an individual basis by the study investigator
Is currently pregnant, breastfeeding, or planning to become pregnant during the study
Is currently enrolled in another clinical study (other than the parent study) or used any investigational drug or device within 30 days prior to Screening
